Saudi Arabia vs Switzerland: Average non-HDL cholesterol levels
Saudi Arabia
3.4
in 2018
Switzerland
3.4
in 2018
Saudi Arabia rank
75th
Switzerland rank
75th
Average non-HDL cholesterol levels over time
- Saudi Arabia
- Switzerland
How they compare
Saudi Arabia currently reports 3.4 against 3.4 in Switzerland, a difference of 0.
Across all 39 years both countries report, Switzerland has been ahead every year.
Saudi Arabia ranks 75th and Switzerland ranks 75th of 191 countries.
Switzerland has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.49 | 4.67 | 1.18 | Switzerland |
| 1990s | 3.5 | 4.42 | 0.92 | Switzerland |
| 2000s | 3.45 | 3.91 | 0.46 | Switzerland |
| 2010s | 3.4 | 3.56 | 0.1556 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Saudi Arabia or Switzerland?
- Saudi Arabia, at 3.4 against 3.4 in Switzerland as of 2018.
- What is the difference in average non-hdl cholesterol levels between Saudi Arabia and Switzerland?
- 0, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Switzerland?
- 39 years are reported by both, from 1980 to 2018.
- How do Saudi Arabia and Switzerland rank globally for average non-hdl cholesterol levels?
- Saudi Arabia ranks 75th and Switzerland ranks 75th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.